"A solid iipid nanoparticles having a drug or plurality of drugs encapsulated therein".
This invention relates to a solid Iipid nanoparticles having a drug or plurality of drugs encapsulated therein and having sustained controlled release of the drug and there is provided a process for the preparation of solid Iipi...
The present invention is related to the development of a novel inter and intra multilamellar vesicular composition containing and antipsoriatic drug dithranol.
demands so. Thus, the product has improved the dithranol therapy along with some additive advantageous features.
A microemulsion organogel system for site-specific delivery of cyclosporin composed of gelator molecules, a polar/aqueous phase, and appropriate organic solvents wherein cyclosporin is in liposolubilzed state in the organogels.
This invention relates to a process for the preparation of alginate nanoparticles having one or more drugs comprising singularly or a combination of rifampicin (RIF), isoniazid (INH), pyrazinamide (PZA) and ethambutol (EMB) encapsulated therein comprising preparing an aqueous solution of said drugs or drugs along wi...
This invention relates to a process for the preparation of poly-DL-lactide-co-glycolide nanoparticles (PLG-NP) having atleast two different active substances with different or same solubility properties encapsulated therein comprising steps of: preparing an aqueous solution of hydrophilic drug in distilled water (DW...
[Class : 5] Pharmaceuticals, Medical And Veterinary Preparations; Sanitary Preparations For Medical Purposes; Dietetic Food And Substances Adapted For Medical Or Veterinary Use, Food For Babies; Dietary Supplements For Human Beings And Animals; Plasters, Materials For Dressings; Material For Stopping Teeth, Dental Wax; Disinfectants; Preparations For Destroying Vermin; Fungi...
View +23 more Brands for Lifecare Innovations Private Limited.
Charges
0
05 October 2009
Technology Development Board
2 Crore
23 May 2011
Department Of Biotechnology
52 Lak
05 October 2009
Technology Development Board
0
23 May 2011
Department Of Biotechnology
0
05 October 2009
Technology Development Board
0
23 May 2011
Department Of Biotechnology
0
05 October 2009
Technology Development Board
0
23 May 2011
Department Of Biotechnology
0
Documents
Form DPT-3-07082020-signed
Form MGT-7-17112019_signed
Form ADT-1-16112019_signed
Form AOC-4-16112019_signed
Form CHG-4-08112019_signed
CERTIFICATE OF SATISFACTION OF CHARGE-20191108
Letter of the charge holder stating that the amount has been satisfied-07112019
List of share holders, debenture holders;-30102019
Form DIR-12-28102019_signed
Optional Attachment-(1)-25102019
Optional Attachment-(2)-25102019
Directors report as per section 134(3)-22102019
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-22102019
Copy of resolution passed by the company-22102019
Copy of written consent given by auditor-22102019
Optional Attachment-(1)-22102019
Auditor?s certificate-28062019
Auditor?s certificate-28062019
Form DPT-3-28062019
Form DIR-12-23102018_signed
Declaration by first director-22102018
Declaration of the appointee director, Managing director, in Form No. DIR-2;-22102018
Interest in other entities;-22102018
List of share holders, debenture holders;-08102018
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-08102018